Generate a tailored SOP for Dr. Carolyn Owen. Improve your application with a focused, well-structured draft.
Dr. Owen's research primarily focuses on the molecular basis of familial myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), investigating inherited hematological malignancies. Her clinical work emphasizes chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma (NHL), particularly through clinical trials in these areas. She has demonstrated significant national leadership in CLL clinical trials, notably as a principal investigator in various studies that have increased patient enrollment at her center, recognized as a leading institution in Canada for hematology clinical trials. Dr. Owen's contributions include authorship of multiple publications, including significant work in the New England Journal of Medicine focusing on innovative agents for CLL and NHL. Her collaboration with the University of Chicago seeks to identify germline predisposing variants in young patients with MDS, as well as her joint research with Dr. Tara Beattie to explore the genetic causes of inherited hematological malignancies.
Department of Computer Science Master's program. GRE scores are expected for international students.